Real-time Estimate
Other stock markets
|
|
5-day change | 1st Jan Change | |
1,427 GBX | -0.39% | -0.55% | -0.66% |
Dec. 07 | European Equities Traded in the US as American Depositary Receipts Flat in Thursday Trading | MT |
Dec. 07 | THG backer Kelso pushes for demerger to trim "inherent" valuation gap | AN |
Chart calendar GSK plc
c3.wRG6FzVsFbmQUn_TmeSI5aajVHmhzlttjzOiolA9e5s.pXDQUQEqfc77EwWA0I_npuLALgj7rQo4unnu4CBYHqq3esxOBQ9E1d89EA~dcebbe62660f5d8ef5000a74a248f89e
Upcoming events on GSK plc
Past events on GSK plc
2023-12-05 | Global Coalition on Aging Silver Economy Forum |
2023-11-30 08:00 am | Investor Meeting - Getting ahead of Respiratory Diseases |
2023-11-29 07:30 am | Evercore ISI HealthCONx Conference |
2023-11-29 04:00 am | The Redburn Atlantic CEO Conference |
2023-11-16 04:00 am | Jefferies London Healthcare Conference |
2023-11-15 | Interim dividend |
2023-11-01 08:00 am | Q3 2023 Earnings Call |
2023-11-01 03:00 am | Q3 2023 Earnings Release |
2023-10-24 | US Centers for Disease Control and Prevention Advisory Committee on Immunization Practices Meeting |
2023-09-28 09:00 am | Investor Meeting - ViiV Healthcare |
2023-09-14 04:05 am | Bank of America Global Healthcare Conference |
2023-09-07 08:50 am | Citi BioPharma Conference |
2023-08-16 | Interim dividend |
2023-07-26 07:00 am | Q2 2023 Earnings Call |
2023-07-26 02:00 am | Q2 2023 Earnings Release |
2023-06-27 09:00 am | Investor Meeting - Getting ahead of Infectious Disease |
2023-06-20 | Immunization Practices Meeting |
2023-06-13 12:20 pm | Goldman Sachs Global Healthcare Conference |
2023-06-06 10:00 am | Investor Meeting - ESG - Clinical Trial Diversity |
2023-05-17 | Interim dividend |
Past dividends on GSK plc
2023-11-15 | Interim Payment 0.14 GBP |
2023-08-16 | Interim Payment 0.14 GBP |
2023-05-17 | Interim Payment 0.14 GBP |
2023-02-22 | Final Payment 0.1375 GBP |
2022-11-16 | Interim Payment 0.1375 GBP |
2022-08-17 | Interim Payment 0.1625 GBP |
2022-07-17 | 0 GBP |
2022-05-18 | Interim Payment 0.14 GBP |
2022-02-23 | Final Payment 0.23 GBP |
2021-11-17 | Interim Payment 0.19 GBP |
Annual results
Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Net sales Million GBP | Released Forecast Spread | 30 821 30 564 0.84% | 33 754 33 382 1.11% | 34 099 34 076 0.07% | 34 114 34 029 0.25% | 29 324 29 105 0.75% | 29 630 |
EBITDA Million GBP | Released Forecast Spread | 10 508 10 277 2.25% | 11 968 11 155 7.28% | 9 530 10 575 -9.88% | 11 330 10 048 12.76% | 10 449 9 257 12.88% | 10 151 |
EBIT Million GBP | Released Forecast Spread | 8 745 8 605 1.63% | 8 972 9 182 -2.29% | 8 906 8 955 -0.55% | 8 806 8 717 1.02% | 8 151 7 952 2.5% | 8 702 |
Earnings before Tax (EBT) Million GBP | Released Forecast Spread | 4 800 5 259 -8.73% | 6 221 5 926 4.97% | 6 968 6 763 3.02% | 5 442 5 794 -6.07% | 5 628 5 548 1.45% | 7 444 |
Net income Million GBP | Released Forecast Spread | 3 623 3 540 2.36% | 4 645 4 026 15.38% | 5 749 4 894 17.46% | 4 385 3 990 9.91% | 14 956 6 339 135.92% | 5 513 |
EPS GBP | Released Forecast Spread | 0,92 0,90 2.77% | 1,16 1,06 9.69% | 1,43 1,21 17.91% | 1,08 1,02 6.28% | 3,66 1,66 120.52% | 1,38 |
Announcement Date | 06/02/19 | 05/02/20 | 03/02/21 | 09/02/22 | 01/02/23 | - |
Quarterly results
Fiscal Period | December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million GBP | Released Forecast Spread | 9 077 8 692 4.43% | 9 527 9 547 -0.21% | 9 780 9 145 6.94% | 6 929 6 906 0.33% | 7 829 7 214 8.52% | 7 376 7 101 3.88% | 6 951 6 580 5.64% | 7 178 6 795 5.63% | 8 147 7 727 5.43% | 7 540 | 7 080 | 7 300 | 8 140 | 7 810 |
EBITDA Million GBP | Released Forecast Spread | 3 860 2 751 40.33% | 2 406 2 392 0.58% | 3 317 2 850 16.4% | 2 639 2 138 23.45% | 3 561 2 704 31.68% | 1 602 1 855 -13.63% | 2 732 2 418 12.97% | 2 622 2 506 4.64% | 3 351 3 072 9.09% | 2 369 | ||||
EBIT Million GBP | Released Forecast Spread | 2 874 2 261 27.09% | 1 893 1 885 0.41% | 2 613 2 291 14.06% | 2 008 1 740 15.4% | 2 605 2 264 15.08% | 1 595 1 509 5.7% | 2 092 1 930 8.42% | 2 170 1 999 8.56% | 2 772 2 570 7.88% | 1 972 | 2 081 | 2 097 | 2 638 | 2 118 |
Earnings before Tax (EBT) Million GBP | Released Forecast Spread | 1 748 1 423 22.88% | 706 812 -13.05% | 2 598 2 268 14.55% | 896 1 243 -27.89% | 1 012 1 860 -45.59% | 1 626 946 71.97% | 1 907 1 529 24.72% | 1 987 1 500 32.51% | 1 791 2 225 -19.51% | 1 296 | ||||
Net income Million GBP | Released Forecast Spread | 1 168 836 39.64% | 749 122 515.71% | 1 802 1 674 7.66% | 975 802 21.54% | 10 315 1 356 660.76% | 1 495 1 151 29.9% | 1 490 1 179 26.41% | 1 624 1 213 33.86% | 1 464 1 739 -15.79% | 1 323 | ||||
EPS GBP | Released Forecast Spread | 0,29 0,24 21.02% | 0,18 0,09 106.69% | 0,45 0,41 8.83% | 0,21 0,21 -3.22% | 2,52 0,34 640.73% | 0,37 0,19 95.19% | 0,37 0,29 27.52% | 0,40 0,30 35.52% | 0,36 0,43 -15.26% | 0,32 | ||||
Announcement Date | 27/10/21 | 09/02/22 | 27/04/22 | 27/07/22 | 02/11/22 | 01/02/23 | 26/04/23 | 26/07/23 | 01/11/23 | - | - | - | - | - |
2024-01-07 | Q2 2024 Earnings Release (Projected) |
2024-01-10 | Q3 2023 Earnings Release |
2024-01-22 | Q3 2024 Earnings Release (Projected) |
2024-01-23 06:20 am | Q4 2023 Earnings Release |
2024-01-24 | Q3 2023 Earnings Release (Projected) |
2024-01-25 | Q4 2023 Earnings Release (Projected) |
2024-01-25 | Q3 2024 Earnings Release (Projected) |
2024-01-28 | Q3 2024 Earnings Release (Projected) |
2024-01-28 | Q3 2023 Earnings Release (Projected) |
2024-01-29 | Q4 2023 Earnings Release (Projected) |
Past sector events for GSK plc
2023-11-29 | Q3 2023 Earnings Release |
2023-11-27 | Q2 2024 Earnings Release |
2023-11-16 01:37 am | Q3 2023 Earnings Release |
2023-11-15 07:30 am | Q3 2023 Earnings Release |
2023-11-15 06:59 am | Q1 2024 Earnings Release |
2023-11-15 01:30 am | Q3 2023 Earnings Release |
2023-11-15 01:30 am | Q3 2023 Earnings Release |
2023-11-14 03:44 am | Q2 2024 Earnings Release |
2023-11-13 | Q3 2023 Earnings Release |
2023-11-13 07:00 am | Q2 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock
- Equities
- Stock GSK plc - London Stock Exchange
- Calendar GSK plc